Skip to main content
Fig. 1 | Journal of Translational Medicine

Fig. 1

From: Role of galectin 3 binding protein in cancer progression: a potential novel therapeutic target

Fig. 1

Structure and domains of LGALS3BP. A Schematic representation of LGALS3BP domains. N and O glycosylation sites and proteins involved in LGALS3BP modification are indicated. N: Asparagine; T: Threonine; S: Serine. B LGALS3BP intracellular and mature forms from neuroblastoma SKNAS whole cell lysate and isolated EVs are shown. CD9 was used as marker for purified EVs preparation

Back to article page